Swedish Orphan Biovit Ord
(BIOVF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BIOVF | ASND | GH | ||
| Company | Swedish Orphan Biovit Ord | Ascendis Pharma ADR | Guardant Health Inc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 37.0000 | 211.00 | 108.00 | ||
| High | 37.0000 | 222.99 | 108.51 | ||
| Low | 37.0000 | 211.00 | 100.28 | ||
| Latest | 37.0000 | 218.10 | 102.76 | ||
| Change | +0.4150 | -3.39 | -4.82 | ||
| % Change | +1.13% | -1.53% | -4.48% | ||
| Volume | 400 | 1,684,400 | 2,006,100 | ||
| 20-Day Average Volume | 490 | 761,835 | 2,046,895 | ||
| Previous Close | 36.5850 | 221.49 | 107.58 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 31.0403 | 222.77 | 110.27 | ||
| 20-Day Raw Stochastic | 100.00% | 42.15% | 22.57% | ||
| 20-Day Relative Strength | 65.02 | 50.24 | 46.35 | ||
| Weighted Alpha | N/A | +47.05 | +94.73 | ||
| Today's Opinion | N/A | 88% Buy | 56% Buy | ||
| Previous Opinion | N/A | 88% Buy | 72% Buy | ||
| Last Month's Opinion | N/A | 96% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +23.15% since 09/17/25 | +0.33% since 02/05/26 | +4.47% since 02/05/26 | ||
| Low | 33.3000 on 10/06/25 | 211.00 on 02/12/26 | 97.52 on 02/06/26 | ||
| High | 37.0000 on 01/14/26 | 226.40 on 02/09/26 | 108.51 on 02/12/26 | ||
| 1-Month | |||||
| %Chg | +4.96% since 12/03/25 | +4.47% since 01/12/26 | -4.47% since 01/12/26 | ||
| Low | 36.5850 on 01/07/26 | 200.68 on 01/20/26 | 97.52 on 02/06/26 | ||
| High | 37.0000 on 01/14/26 | 242.00 on 01/28/26 | 120.74 on 01/22/26 | ||
| 3-Month | |||||
| %Chg | +11.11% since 10/06/25 | +9.48% since 11/12/25 | +5.03% since 11/12/25 | ||
| Low | 34.8800 on 11/04/25 | 188.07 on 11/13/25 | 90.43 on 11/14/25 | ||
| High | 37.0000 on 01/14/26 | 242.00 on 01/28/26 | 120.74 on 01/22/26 | ||
| 6-Month | |||||
| %Chg | +26.50% since 06/26/25 | +11.29% since 08/12/25 | +86.50% since 08/12/25 | ||
| Low | 28.9350 on 08/12/25 | 186.05 on 10/20/25 | 53.40 on 09/16/25 | ||
| High | 37.0000 on 01/14/26 | 242.00 on 01/28/26 | 120.74 on 01/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 13,172,000 | 13,517,184 | 12,951,974 | ||
| Shares Outstanding, K | 356,000 | 61,977 | 126,041 | ||
| Annual Sales | 2,886,350,000 | 393,500,000 | 739,020,000 | ||
| Annual Net Income | 48,860,000 | -409,120,000 | -436,370,000 | ||
| Last Quarter Sales | 817,260,000 | 249,720,000 | 265,200,000 | ||
| Last Quarter Net Income | -304,160,000 | -71,290,000 | -92,730,000 | ||
| 60-Month Beta | 0.37 | 0.44 | 1.63 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.64 on 10/20/25 | -1.17 on 11/12/25 | -0.39 on 10/29/25 | ||
| Latest Earnings Date | 05/05/26 | 05/07/26 | 02/19/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 24.23 | 0.00 | 0.00 | ||